192 related articles for article (PubMed ID: 21130668)
21. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
22. Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease: six new cases and a short literature review.
Kim DS; Jang DK; Huh PW; Yoo DS; Han YM; Huh CW
Acta Neurochir (Wien); 2011 Jun; 153(6):1253-61. PubMed ID: 21212995
[TBL] [Abstract][Full Text] [Related]
23. Ischemic Stroke and Intraventricular Hemorrhage in Moyamoya Syndrome Associated With Graves' Disease: A Case Report.
Huang M; Tang S; Zou Y; Yang G; Nan Y; Li Y; Zhang C
Neurologist; 2023 Jan; 28(1):42-45. PubMed ID: 35452440
[TBL] [Abstract][Full Text] [Related]
24. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
25. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
26. Moyamoya syndrome with primary antiphospholipid syndrome.
Shuja-Ud-Din MA; Ahamed SA; Baidas G; Naeem M
Med Princ Pract; 2006; 15(3):238-41. PubMed ID: 16651844
[TBL] [Abstract][Full Text] [Related]
27. Complex investigation of Graves'-Basedow disease: case report.
Luca IC; Bene MC; Cotuţiu C
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
[TBL] [Abstract][Full Text] [Related]
29. Acute ataxia, Graves' disease, and stiff person syndrome.
Chia SY; Chua R; Lo YL; Wong MC; Chan LL; Tan EK
Mov Disord; 2007 Oct; 22(13):1969-71. PubMed ID: 17712846
[TBL] [Abstract][Full Text] [Related]
30. Acute Thyrotoxicosis of Graves Disease Associated with Moyamoya Vasculopathy and Stroke in Latin American Women: A Case Series and Review of the Literature.
Shah NH; Khandelwal P; Gordon-Perue G; Shah AH; Barbarite E; Ortiz G; Forteza AM
World Neurosurg; 2016 Aug; 92():95-107. PubMed ID: 27163552
[TBL] [Abstract][Full Text] [Related]
31. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome.
Sharfstein SR; Ahmed S; Islam MQ; Najjar MI; Ratushny V
J Stroke Cerebrovasc Dis; 2007; 16(6):268-72. PubMed ID: 18035245
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and disease progression in moyamoya disease patients with Graves disease.
Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
[TBL] [Abstract][Full Text] [Related]
33. [Hyperperfusion after Revascularization for Quasi-moyamoya Disease Associated with Graves' Disease:A Case Report].
Shimonaga K; Mitsuhara T; Hosogai M; Kawasumi T
No Shinkei Geka; 2018 Jun; 46(6):501-508. PubMed ID: 29930211
[TBL] [Abstract][Full Text] [Related]
34. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease.
Endo H; Fujimura M; Niizuma K; Shimizu H; Tominaga T
Neurol Med Chir (Tokyo); 2010; 50(11):977-83. PubMed ID: 21123980
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
37. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].
Nanba R; Kuroda S; Takeda M; Shichinohe H; Nakayama N; Ishikawa T; Houkin K; Iwasaki Y
No Shinkei Geka; 2003 Dec; 31(12):1291-5. PubMed ID: 14719442
[TBL] [Abstract][Full Text] [Related]
39. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
Höfer R
Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
[TBL] [Abstract][Full Text] [Related]
40. [Thyrotoxic crisis in a patient with Graves' disease].
Pruijm MT; Pereira AM
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1691-4. PubMed ID: 15453122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
